EISAI-E2007-G000-304

Study Sponsor: Eisai

Study Title

A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Medicine or Vaccine (generic name)

perampanel

Sponsor Identification Number

E2007-G000-304

Trial Registry Identification Number(#'s)

NCT00699972
EU CTR 2007-006191-11

Medical Condition

Refractory Partial Seizures

Phase

Phase 3

Link to study details on the Eisai Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/NCT00699972

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-006191-11

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

No restrictions.

Date Added to this Site

November 2018